Hopes for tuberculosis treatment have been raised by an international study in which DZIF scientists from the Research Center Borstel were also involved. Resistance to pyrazinamide und
An international team of scientists has had unexpected success in treating tuberculosis with a ß-lactam antibiotic that is approved for other indications. DZIF scientists from the Research Center
PanACEA, the Pan-African Consortium for the Evaluation of Antituberculosis Antibiotics, presented the results of its most recent phase IIb study. The most exciting finding from the study is that high
